Stay updated on LOU064 Efficacy and Safety in CSU Clinical Trial

Sign up to get notified when there's something new on the LOU064 Efficacy and Safety in CSU Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LOU064 Efficacy and Safety in CSU Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a modification in the dosing groups of oral LOU064 being studied in patients with chronic spontaneous urticaria (CSU) inadequately controlled by H1-antihistamines.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:03.000Z thumbnail image
  6. Check
    20 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for study participants, specifying the required age, CSU diagnosis duration, and other health conditions. Previously, no information was provided under the Participation Criteria Collaborators section.
    Difference
    15%
    Check dated 2024-05-22T20:55:02.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:39:22.000Z thumbnail image

Stay in the know with updates to LOU064 Efficacy and Safety in CSU Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LOU064 Efficacy and Safety in CSU Clinical Trial page.